欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aquifex aeolicus Uncharacterized protein aq_522 (aq_522), partial CSB-YP524702DNV
CSB-EP524702DNV
CSB-BP524702DNV
CSB-MP524702DNV
CSB-EP524702DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0056 membrane protein aq_540 (aq_540), partial CSB-YP524703DNV1
CSB-EP524703DNV1
CSB-BP524703DNV1
CSB-MP524703DNV1
CSB-EP524703DNV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus NADH-quinone oxidoreductase subunit C/D 1 (nuoC1), partial CSB-YP524704DNV
CSB-EP524704DNV
CSB-BP524704DNV
CSB-MP524704DNV
CSB-EP524704DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus DNA repair protein recN (recN), partial CSB-YP524705DNV
CSB-EP524705DNV
CSB-BP524705DNV
CSB-MP524705DNV
CSB-EP524705DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Uncharacterized HTH-type transcriptional regulator aq_603 (aq_603) CSB-YP524706DNV
CSB-EP524706DNV
CSB-BP524706DNV
CSB-MP524706DNV
CSB-EP524706DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Putative 8-amino-7-oxononanoate synthase (bioF) CSB-YP524707DNV
CSB-EP524707DNV
CSB-BP524707DNV
CSB-MP524707DNV
CSB-EP524707DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UvrABC system protein A (uvrA), partial CSB-YP524708DNV
CSB-EP524708DNV
CSB-BP524708DNV
CSB-MP524708DNV
CSB-EP524708DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Tryptophan synthase beta chain 1 (trpB1) CSB-YP524709DNV
CSB-EP524709DNV
CSB-BP524709DNV
CSB-MP524709DNV
CSB-EP524709DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Glycogen synthase (glgA) CSB-YP524710DNV
CSB-EP524710DNV
CSB-BP524710DNV
CSB-MP524710DNV
CSB-EP524710DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0118 membrane protein aq_740 (aq_740), partial CSB-YP524711DNV
CSB-EP524711DNV
CSB-BP524711DNV
CSB-MP524711DNV
CSB-EP524711DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0128 protein aq_756 (aq_756) CSB-YP524712DNV
CSB-EP524712DNV
CSB-BP524712DNV
CSB-MP524712DNV
CSB-EP524712DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0097 protein aq_768 (aq_768) CSB-YP524713DNV
CSB-EP524713DNV
CSB-BP524713DNV
CSB-MP524713DNV
CSB-EP524713DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP524714DNV
CSB-EP524714DNV
CSB-BP524714DNV
CSB-MP524714DNV
CSB-EP524714DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus 5'-nucleotidase surE (surE) CSB-YP524715DNV
CSB-EP524715DNV
CSB-BP524715DNV
CSB-MP524715DNV
CSB-EP524715DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0079 ATP-binding protein aq_843 (aq_843) CSB-YP524716DNV
CSB-EP524716DNV
CSB-BP524716DNV
CSB-MP524716DNV
CSB-EP524716DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0753 protein aq_863 (aq_863), partial CSB-YP524717DNV
CSB-EP524717DNV
CSB-BP524717DNV
CSB-MP524717DNV
CSB-EP524717DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UPF0278 protein aq_880 (aq_880) CSB-YP524718DNV
CSB-EP524718DNV
CSB-BP524718DNV
CSB-MP524718DNV
CSB-EP524718DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus tRNA-specific adenosine deaminase (tadA) CSB-YP524719DNV
CSB-EP524719DNV
CSB-BP524719DNV
CSB-MP524719DNV
CSB-EP524719DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Signal recognition particle receptor FtsY (ftsY) CSB-YP524720DNV
CSB-EP524720DNV
CSB-BP524720DNV
CSB-MP524720DNV
CSB-EP524720DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP524721DNV
CSB-EP524721DNV
CSB-BP524721DNV
CSB-MP524721DNV
CSB-EP524721DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×